HRT Financial’s Sight Sciences SGHT Stock Holding History

HRT Financial’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-79,414	Closed	-$1.4M	–	3784
2021 Q4	$1.4M	Buy	+79,414	New	+$1.74M	0.01%	883

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

HRT Financial's SGHT Position: Q1 2022 in Review

HRT Financial sold out of Sight Sciences (SGHT) in Q1 2022, closing a stake of 79,414 shares — an estimated $1.4M sold.

HRT Financial first reported a position in SGHT in Q4 2021 and held it in 1 quarter. The position peaked at $1.4M in Q4 2021. 66 funds tracked by Wall St. Rank hold SGHT as of Q1 2022.

HRT Financial reported no remaining Sight Sciences position as of Q1 2022 after selling out during the quarter.
HRT Financial sold 79,414 Sight Sciences shares in Q1 2022, an estimated $1.4M.
HRT Financial first reported a position in Sight Sciences in Q4 2021 and held it in 1 quarter.
HRT Financial's Sight Sciences position peaked at $1.4M in Q4 2021.
66 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.